Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
Kishimoto
Mitsumasa
M
Oishi
Ai
A
Motojima
Shinji
S
D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D013997:Time Factors
D050071:Bone Density Conservation Agents; D005938:Glucocorticoids; D006887:Hydroxycholecalciferols; C008088:alfacalcidol; D019386:Alendronate